Clinical Trial

Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness

Study acronym: STELO-GLOW
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this prospective observational study is to gather exploratory and practical use data of the Dexcom Stelo Glucose Biosensing System (Stelo), an over-the-counter (OTC) real-time Continuous Glucose Monitoring (CGM) system among patients with Gestational Diabetes Mellitus (GDM) in their most recent pregnancy.
Trial Details
NCT Number NCT07356986
Lead Sponsor Oregon Health and Science University
Collaborators: DexCom, Inc., University of Pennsylvania, Sansum Diabetes Research Institute
Conditions Gestational Diabetes, Postpartum
Enrollment 50 participants
Start Date 2026-01
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-21